{
    "title": "Molecular Partners shares rise on Swiss govt COVID drug deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8614699/Molecular-Partners-gets-Swiss-govt-payment-COVID-candidate.html",
    "date": "2020-08-11",
    "keywords": [
        "drug",
        "company",
        "deal",
        "miller",
        "tuesday",
        "government",
        "abicipar",
        "vaccine",
        "biotechnology",
        "firm",
        "multimillion",
        "dollar",
        "candidate",
        "covid19",
        "failure",
        "eye",
        "treatment",
        "mp0420",
        "novel",
        "coronavirus",
        "week",
        "moderna",
        "supply",
        "agreement",
        "right",
        "potential",
        "year",
        "penetration",
        "virus",
        "immune",
        "system",
        "health",
        "hopeful",
        "interest",
        "part",
        "therapy",
        "risk",
        "infection",
        "role",
        "head",
        "office",
        "division",
        "approach",
        "ground",
        "care",
        "immunization",
        "kronig",
        "interview",
        "news",
        "june",
        "partnership",
        "food",
        "administration",
        "approval",
        "degeneration",
        "capital",
        "increase",
        "reporting",
        "john",
        "editing",
        "jacqueline",
        "wong",
        "michael",
        "jan",
        "harvey"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}